Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Mar 7;40(17):1939–1948. doi: 10.1200/JCO.21.01805

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 by American Society of Clinical Oncology

Creative Commons Attribution Non-Commercial No Derivatives 4.0 License: https://creativecommons.org/licenses/by-nc-nd/4.0/

PMC Copyright notice

FIG 4. — OS for tebentafusp-treated metastatic uveal melanoma patients. (A) Kaplan-Meier plot of OS (N = 42). Events are deaths because of any cause. Patients not known to have died at the time of analysis are censored. Median (95% CI) is 25.5 (12.4 to 31.1) months. (B) Kaplan-Meier plot of OS by rash (any grade) within 7 days (N = 42). Hazard ratio (95% CI) for rash: 0.235 (0.101 to 0.544). Rash is a composite term for a list of skin toxicities of any grade (Data supplement). OS, overall survival.